Clinical Trial Detail

NCT ID NCT01312857
Title Study of Hepatic Arterial Infusion With Intravenous Irinotecan, 5FU and Leucovorin With or Without Panitumumab, in Patients With Wild Type KRAS Who Have Resected Hepatic Metastases From Colorectal Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements yes
Sponsors Memorial Sloan-Kettering Cancer Center
Indications

colorectal cancer

Therapies

Panitumumab

Fluorouracil + Irinotecan + Leucovorin

Floxuridine

Age Groups: adult

Additional content available in CKB BOOST